These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8484412)

  • 1. Long-term outcome of Hurler syndrome following bone marrow transplantation.
    Whitley CB; Belani KG; Chang PN; Summers CG; Blazar BR; Tsai MY; Latchaw RE; Ramsay NK; Kersey JH
    Am J Med Genet; 1993 Apr; 46(2):209-18. PubMed ID: 8484412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome of second hematopoietic cell transplantation in Hurler syndrome.
    Grewal SS; Krivit W; Defor TE; Shapiro EG; Orchard PJ; Abel SL; Lockman LA; Ziegler RS; Dusenbery KE; Peters C
    Bone Marrow Transplant; 2002 Mar; 29(6):491-6. PubMed ID: 11960268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hurler syndrome: II. Outcome of HLA-genotypically identical sibling and HLA-haploidentical related donor bone marrow transplantation in fifty-four children. The Storage Disease Collaborative Study Group.
    Peters C; Shapiro EG; Anderson J; Henslee-Downey PJ; Klemperer MR; Cowan MJ; Saunders EF; deAlarcon PA; Twist C; Nachman JB; Hale GA; Harris RE; Rozans MK; Kurtzberg J; Grayson GH; Williams TE; Lenarsky C; Wagner JE; Krivit W
    Blood; 1998 Apr; 91(7):2601-8. PubMed ID: 9516162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of unrelated donor bone marrow transplantation in 40 children with Hurler syndrome.
    Peters C; Balthazor M; Shapiro EG; King RJ; Kollman C; Hegland JD; Henslee-Downey J; Trigg ME; Cowan MJ; Sanders J; Bunin N; Weinstein H; Lenarsky C; Falk P; Harris R; Bowen T; Williams TE; Grayson GH; Warkentin P; Sender L; Cool VA; Crittenden M; Packman S; Kaplan P; Lockman LA; Anderson J; Krivit W; Dusenbery K; Wagner J
    Blood; 1996 Jun; 87(11):4894-902. PubMed ID: 8639864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome.
    Staba SL; Escolar ML; Poe M; Kim Y; Martin PL; Szabolcs P; Allison-Thacker J; Wood S; Wenger DA; Rubinstein P; Hopwood JJ; Krivit W; Kurtzberg J
    N Engl J Med; 2004 May; 350(19):1960-9. PubMed ID: 15128896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laronidase for cardiopulmonary disease in Hurler syndrome 12 years after bone marrow transplantation.
    Valayannopoulos V; de Blic J; Mahlaoui N; Stos B; Jaubert F; Bonnet D; Fischer A; de Lonlay P
    Pediatrics; 2010 Nov; 126(5):e1242-7. PubMed ID: 20974778
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed donor chimerism and low level iduronidase expression may be adequate for neurodevelopmental protection in Hurler Syndrome.
    Conway J; Dyack S; Crooks BN; Fernandez CV
    J Pediatr; 2005 Jul; 147(1):106-8. PubMed ID: 16027706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hematopoietic Stem- and Progenitor-Cell Gene Therapy for Hurler Syndrome.
    Gentner B; Tucci F; Galimberti S; Fumagalli F; De Pellegrin M; Silvani P; Camesasca C; Pontesilli S; Darin S; Ciotti F; Sarzana M; Consiglieri G; Filisetti C; Forni G; Passerini L; Tomasoni D; Cesana D; Calabria A; Spinozzi G; Cicalese MP; Calbi V; Migliavacca M; Barzaghi F; Ferrua F; Gallo V; Miglietta S; Zonari E; Cheruku PS; Forni C; Facchini M; Corti A; Gabaldo M; Zancan S; Gasperini S; Rovelli A; Boelens JJ; Jones SA; Wynn R; Baldoli C; Montini E; Gregori S; Ciceri F; Valsecchi MG; la Marca G; Parini R; Naldini L; Aiuti A; Bernardo ME;
    N Engl J Med; 2021 Nov; 385(21):1929-1940. PubMed ID: 34788506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of partially HLA-mismatched donors for allogeneic transplantation in patients with mucopolysaccharidosis-I.
    Fleming DR; Henslee-Downey PJ; Ciocci G; Romond EH; Marciniak E; Munn RK; Thompson JS
    Pediatr Transplant; 1998 Nov; 2(4):299-304. PubMed ID: 10084733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow transplantation in canine mucopolysaccharidosis I. Effects within the central nervous system.
    Shull RM; Hastings NE; Selcer RR; Jones JB; Smith JR; Cullen WC; Constantopoulos G
    J Clin Invest; 1987 Feb; 79(2):435-43. PubMed ID: 3100576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental outcome in five children with Hurler syndrome after stem cell transplantation: a pilot study.
    Lücke T; Das AM; Hartmann H; Sykora KW; Donnerstag F; Schmid-Ott G; Grigull L
    Dev Med Child Neurol; 2007 Sep; 49(9):693-6. PubMed ID: 17718826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome.
    Tolar J; Grewal SS; Bjoraker KJ; Whitley CB; Shapiro EG; Charnas L; Orchard PJ
    Bone Marrow Transplant; 2008 Mar; 41(6):531-5. PubMed ID: 18037941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Bone marrow transplantation in mucopolysaccharidosis type I, Hurler-Scheie variety. Metabolic correction and clinical results].
    Ortega Aramburu JJ; Domínguez Luengo C; Olivé Oliveras T; Navarro Fernández C
    An Esp Pediatr; 1990 Oct; 33(4):369-75. PubMed ID: 2126172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral busulfan pharmacokinetics and engraftment in children with Hurler syndrome and other inherited metabolic storage diseases undergoing hematopoietic cell transplantation.
    Jacobson P; Park JJ; DeFor TE; Thrall M; Abel S; Krivit W; Peters C
    Bone Marrow Transplant; 2001 Apr; 27(8):855-61. PubMed ID: 11477444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Life-threatening pulmonary hemorrhages post bone marrow transplantation in Hurler syndrome. Report of three cases and review of the literature.
    Gassas A; Sung L; Doyle JJ; Clarke JT; Saunders EF
    Bone Marrow Transplant; 2003 Jul; 32(2):213-5. PubMed ID: 12838287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hurler syndrome with severe complication in post-bone marrow transplantation course: life threatening interstitial pneumonitis and hypertension.
    Ohashi T; Tahara T; Fujisawa K; Hoshi Y; Ito F; Suzuki N; Eto Y; Maekawa K
    Acta Paediatr Jpn; 1995 Dec; 37(6):697-700. PubMed ID: 8775554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for canine alpha-L-iduronidase deficiency: in utero adoptive transfer of genetically corrected hematopoietic progenitors results in engraftment but not amelioration of disease.
    Lutzko C; Omori F; Abrams-Ogg AC; Shull R; Li L; Lau K; Ruedy C; Nanji S; Gartley C; Dobson H; Foster R; Kruth S; Dubé ID
    Hum Gene Ther; 1999 Jun; 10(9):1521-32. PubMed ID: 10395377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow transplantation for Hurler syndrome: assessment of metabolic correction.
    Whitley CB; Ramsay NK; Kersey JH; Krivit W
    Birth Defects Orig Artic Ser; 1986; 22(1):7-24. PubMed ID: 3083887
    [No Abstract]   [Full Text] [Related]  

  • 19. Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).
    Malm G; Gustafsson B; Berglund G; Lindström M; Naess K; Borgström B; von Döbeln U; Ringdén O
    Acta Paediatr; 2008 Aug; 97(8):1108-12. PubMed ID: 18452566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correction of odontoid dysplasia following bone-marrow transplantation and engraftment (in Hurler syndrome MPS 1H).
    Hite SH; Peters C; Krivit W
    Pediatr Radiol; 2000 Jul; 30(7):464-70. PubMed ID: 10929365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.